Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome

Geeta Gyamlani, Miklos Z. Molnar, Jun L. Lu, Keiichi Sumida, Kamyar Kalantar-Zadeh, Csaba Kovesdy

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background. Prior small studies have suggested an association between low serum albumin and increased risk of venous thromboembolic (VTE) events in patients with nephrotic syndrome (NS). Methods. From a nationally representative prospective cohort of over 3 million US veterans with baseline estimated glomerular filtration rate (eGFR) 60 mL/min/1.73 m2, we identified 7037 patients with NS based on ICD-9 codes. Association between serum albumin and risk of incident VTE was assessed using Cox regression analysis with adjustments for age, gender, race, comorbidities, eGFR, body mass index and anticoagulant treatment. Results. Mean age was 57 6 11 years, patients were 96% male, 32% African-American and 60% diabetic. There were a total of 158 VTE events over a median follow-up of 8.1 years; 16 events [absolute event rate (AER) 4.1%, event rate 8.5/1000 patientyears (PY)] in patients with albumin <2.5 g/dL, 18 events (AER 3.4%, event rate 5.7/1000 patient-years) in patients with albumin 2.5-2.99 g/dL, 89 events (AER 2.5%, event rate 3.4/1000 patient-years) in patients with albumin 3-3.99 g/dL and 35 events (AER 1.4%, event rate 1.9/1000 patient-years) in patients with albumin 4 g/dL. Compared with patients with albumin 4 g/dL, those with albumin levels of 3-3.99 g/dL [adjusted hazard ratio (HR): 1.51, 95% confidence interval (CI): 1.01- 2.26], 2.5-2.99 g/dL (HR: 2.24, 95% CI: 1.24-4.05) and <2.5 g/dL (HR: 2.79, 95% CI: 1.45-5.37) experienced a linearly higher risk of VTE events. Conclusions. Lower serum albumin is a strong independent predictor for VTE events in NS. The risk increases proportionately with declining albumin levels. Clinical trials are needed to determine benefit of prophylactic anticoagulation in NS patients with moderately lower serumalbumin levels.

Original languageEnglish (US)
Pages (from-to)157-164
Number of pages8
JournalNephrology Dialysis Transplantation
Volume32
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Nephrotic Syndrome
Serum Albumin
Albumins
International Classification of Diseases
Confidence Intervals
Glomerular Filtration Rate
Veterans
African Americans
Anticoagulants
Comorbidity
Body Mass Index
Regression Analysis
Clinical Trials

All Science Journal Classification (ASJC) codes

  • Nephrology
  • Transplantation

Cite this

Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome. / Gyamlani, Geeta; Molnar, Miklos Z.; Lu, Jun L.; Sumida, Keiichi; Kalantar-Zadeh, Kamyar; Kovesdy, Csaba.

In: Nephrology Dialysis Transplantation, Vol. 32, No. 1, 01.01.2017, p. 157-164.

Research output: Contribution to journalArticle

Gyamlani, Geeta ; Molnar, Miklos Z. ; Lu, Jun L. ; Sumida, Keiichi ; Kalantar-Zadeh, Kamyar ; Kovesdy, Csaba. / Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome. In: Nephrology Dialysis Transplantation. 2017 ; Vol. 32, No. 1. pp. 157-164.
@article{522b7aa8366f4b4abfb034f054a8ce25,
title = "Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome",
abstract = "Background. Prior small studies have suggested an association between low serum albumin and increased risk of venous thromboembolic (VTE) events in patients with nephrotic syndrome (NS). Methods. From a nationally representative prospective cohort of over 3 million US veterans with baseline estimated glomerular filtration rate (eGFR) 60 mL/min/1.73 m2, we identified 7037 patients with NS based on ICD-9 codes. Association between serum albumin and risk of incident VTE was assessed using Cox regression analysis with adjustments for age, gender, race, comorbidities, eGFR, body mass index and anticoagulant treatment. Results. Mean age was 57 6 11 years, patients were 96{\%} male, 32{\%} African-American and 60{\%} diabetic. There were a total of 158 VTE events over a median follow-up of 8.1 years; 16 events [absolute event rate (AER) 4.1{\%}, event rate 8.5/1000 patientyears (PY)] in patients with albumin <2.5 g/dL, 18 events (AER 3.4{\%}, event rate 5.7/1000 patient-years) in patients with albumin 2.5-2.99 g/dL, 89 events (AER 2.5{\%}, event rate 3.4/1000 patient-years) in patients with albumin 3-3.99 g/dL and 35 events (AER 1.4{\%}, event rate 1.9/1000 patient-years) in patients with albumin 4 g/dL. Compared with patients with albumin 4 g/dL, those with albumin levels of 3-3.99 g/dL [adjusted hazard ratio (HR): 1.51, 95{\%} confidence interval (CI): 1.01- 2.26], 2.5-2.99 g/dL (HR: 2.24, 95{\%} CI: 1.24-4.05) and <2.5 g/dL (HR: 2.79, 95{\%} CI: 1.45-5.37) experienced a linearly higher risk of VTE events. Conclusions. Lower serum albumin is a strong independent predictor for VTE events in NS. The risk increases proportionately with declining albumin levels. Clinical trials are needed to determine benefit of prophylactic anticoagulation in NS patients with moderately lower serumalbumin levels.",
author = "Geeta Gyamlani and Molnar, {Miklos Z.} and Lu, {Jun L.} and Keiichi Sumida and Kamyar Kalantar-Zadeh and Csaba Kovesdy",
year = "2017",
month = "1",
day = "1",
doi = "10.1093/ndt/gfw227",
language = "English (US)",
volume = "32",
pages = "157--164",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome

AU - Gyamlani, Geeta

AU - Molnar, Miklos Z.

AU - Lu, Jun L.

AU - Sumida, Keiichi

AU - Kalantar-Zadeh, Kamyar

AU - Kovesdy, Csaba

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Background. Prior small studies have suggested an association between low serum albumin and increased risk of venous thromboembolic (VTE) events in patients with nephrotic syndrome (NS). Methods. From a nationally representative prospective cohort of over 3 million US veterans with baseline estimated glomerular filtration rate (eGFR) 60 mL/min/1.73 m2, we identified 7037 patients with NS based on ICD-9 codes. Association between serum albumin and risk of incident VTE was assessed using Cox regression analysis with adjustments for age, gender, race, comorbidities, eGFR, body mass index and anticoagulant treatment. Results. Mean age was 57 6 11 years, patients were 96% male, 32% African-American and 60% diabetic. There were a total of 158 VTE events over a median follow-up of 8.1 years; 16 events [absolute event rate (AER) 4.1%, event rate 8.5/1000 patientyears (PY)] in patients with albumin <2.5 g/dL, 18 events (AER 3.4%, event rate 5.7/1000 patient-years) in patients with albumin 2.5-2.99 g/dL, 89 events (AER 2.5%, event rate 3.4/1000 patient-years) in patients with albumin 3-3.99 g/dL and 35 events (AER 1.4%, event rate 1.9/1000 patient-years) in patients with albumin 4 g/dL. Compared with patients with albumin 4 g/dL, those with albumin levels of 3-3.99 g/dL [adjusted hazard ratio (HR): 1.51, 95% confidence interval (CI): 1.01- 2.26], 2.5-2.99 g/dL (HR: 2.24, 95% CI: 1.24-4.05) and <2.5 g/dL (HR: 2.79, 95% CI: 1.45-5.37) experienced a linearly higher risk of VTE events. Conclusions. Lower serum albumin is a strong independent predictor for VTE events in NS. The risk increases proportionately with declining albumin levels. Clinical trials are needed to determine benefit of prophylactic anticoagulation in NS patients with moderately lower serumalbumin levels.

AB - Background. Prior small studies have suggested an association between low serum albumin and increased risk of venous thromboembolic (VTE) events in patients with nephrotic syndrome (NS). Methods. From a nationally representative prospective cohort of over 3 million US veterans with baseline estimated glomerular filtration rate (eGFR) 60 mL/min/1.73 m2, we identified 7037 patients with NS based on ICD-9 codes. Association between serum albumin and risk of incident VTE was assessed using Cox regression analysis with adjustments for age, gender, race, comorbidities, eGFR, body mass index and anticoagulant treatment. Results. Mean age was 57 6 11 years, patients were 96% male, 32% African-American and 60% diabetic. There were a total of 158 VTE events over a median follow-up of 8.1 years; 16 events [absolute event rate (AER) 4.1%, event rate 8.5/1000 patientyears (PY)] in patients with albumin <2.5 g/dL, 18 events (AER 3.4%, event rate 5.7/1000 patient-years) in patients with albumin 2.5-2.99 g/dL, 89 events (AER 2.5%, event rate 3.4/1000 patient-years) in patients with albumin 3-3.99 g/dL and 35 events (AER 1.4%, event rate 1.9/1000 patient-years) in patients with albumin 4 g/dL. Compared with patients with albumin 4 g/dL, those with albumin levels of 3-3.99 g/dL [adjusted hazard ratio (HR): 1.51, 95% confidence interval (CI): 1.01- 2.26], 2.5-2.99 g/dL (HR: 2.24, 95% CI: 1.24-4.05) and <2.5 g/dL (HR: 2.79, 95% CI: 1.45-5.37) experienced a linearly higher risk of VTE events. Conclusions. Lower serum albumin is a strong independent predictor for VTE events in NS. The risk increases proportionately with declining albumin levels. Clinical trials are needed to determine benefit of prophylactic anticoagulation in NS patients with moderately lower serumalbumin levels.

UR - http://www.scopus.com/inward/record.url?scp=85016178590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016178590&partnerID=8YFLogxK

U2 - 10.1093/ndt/gfw227

DO - 10.1093/ndt/gfw227

M3 - Article

VL - 32

SP - 157

EP - 164

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 1

ER -